1)Allen RP, Picchietti D, Hening WA, et a1.The par-ticipants in the Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Insti-tutes of Health in collaboration with members of the International Restless Legs Syndrome Study Group, Restless legs syndrome:diagnostic crite-ria, special considerations, and epidemiology. Sleep Med 2003;4:101-19.
2)Trenkwalder C, Paulus W. Restless legs syndrome:pathophysiuology, clillical presentation and man-agement. Nat Rev Neurol 2010;6:337-46.
3)Turjanski N, Lees N, Brooks DL Striatal dopam-inergic function in restless legs syndrome:[u18]F-dopa and [u11]C-raclopride PET studies. Neurology 1999;52:932-7.
4)Trenkwalder C, Walters AS, Henning WA, et al.Positron emission tomographic studies in restless legs syndrome. Mov Disord 1999;14:141-5.
5)Eisensehr I, Wetter TC, Linke R, et al. Normal IPT and IBZM SPECT in drug-naive and levodopa-re-1ated idiopathic restless legs syndrome. Neurology 2001;57:1307-9.